Nbt Bank N A Abb Vie Inc. Transaction History

Nbt Bank N A

$1.47 Billion
Q3 2024

A detailed history of Nbt Bank N A transactions in Abb Vie Inc. stock. As of the latest transaction made, Nbt Bank N A holds 56,766 shares of ABBV stock, worth $10.1 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

56,766

Previous 58,122 2.33%

Holding current value

$10.1 Million

Previous $9.97 Million 12.45%

% of portfolio

0.76%

Previous 0.72%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $222,167 - $270,291	-1,356 Reduced 2.33%	56,766 $11.2 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $714,975 - $834,930	-4,619 Reduced 7.36%	58,122 $9.97 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $407,860 - $464,719	-2,552 Reduced 3.91%	62,741 $11.4 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $44,995 - $50,675	327 Added 0.5%	65,293 $10.1 Million
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $3.98 Million - $4.61 Million	29,785 Added 84.66%	64,966 $9.68 Million
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $139,002 - $172,980	-1,049 Reduced 2.9%	35,181 $4.74 Million
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $164,855 - $189,855	-1,140 Reduced 3.05%	36,230 $5.77 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $113,414 - $136,013	820 Added 2.24%	37,370 $6.04 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $316,601 - $363,120	-2,359 Reduced 6.06%	36,550 $4.91 Million
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $16,652 - $21,170	121 Added 0.31%	38,909 $5.96 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $119,177 - $147,866	-903 Reduced 2.28%	38,788 $6.29 Million
Q4 2021 Jan 27, 2022	SELL	$107.43 - $135.93 $2,685 - $3,398	-25 Reduced 0.06%	39,691 $5.38 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $74,480 - $84,546	-700 Reduced 1.73%	39,716 $4.28 Million
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $38,927 - $43,367	-370 Reduced 0.91%	40,416 $4.55 Million
Q1 2021 Apr 08, 2021	SELL	$102.3 - $112.62 $302,398 - $332,904	-2,956 Reduced 6.76%	40,786 $4.41 Million
Q4 2020 Jan 15, 2021	SELL	$80.49 - $108.67 $159,048 - $214,731	-1,976 Reduced 4.32%	43,742 $4.69 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $124,655 - $146,304	1,451 Added 3.28%	45,718 $4.01 Million
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $153,049 - $204,803	-2,086 Reduced 4.5%	44,267 $4.35 Million
Q1 2020 Apr 23, 2020	SELL	$64.5 - $97.79 $151,317 - $229,415	-2,346 Reduced 4.82%	46,353 $3.53 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $33,324 - $41,695	462 Added 0.96%	48,699 $4.31 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $57,437 - $69,056	-912 Reduced 1.86%	48,237 $3.65 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $23,520 - $30,064	-358 Reduced 0.72%	49,149 $3.57 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $285,803 - $336,376	-3,705 Reduced 6.96%	49,507 $3.99 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $144,022 - $177,618	-1,850 Reduced 3.36%	53,212 $4.91 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $434,592 - $483,129	-4,888 Reduced 8.15%	55,062 $5.21 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $915,486 - $1.08 Million	-10,197 Reduced 14.54%	59,950 $5.55 Million
Q1 2018 May 22, 2018	SELL	$92.01 - $123.21 $375,400 - $502,696	-4,080 Reduced 5.5%	70,147 $6.64 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $783,829 - $859,533	-8,752 Reduced 10.55%	74,227 $7.18 Million
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $42,748 - $54,602	-612 Reduced 0.73%	82,979 $7.37 Million
Q2 2017 Aug 08, 2017	BUY	N/A	83,591	83,591 $6.06 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account